Adverse effects of brompheniramine on pulmonary function in a subset of asthmatic children.

Author: SchullerD E

Paper Details 
Original Abstract of the Article :
The role of antihistamines in the therapy of bronchial asthma has remained controversial. Early studies suggested a possible aggravation of symptoms but more recent studies implied their safety. Ten asthmatic children who reported a feeling of chest tightness and subsequent wheezing after taking a p...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/0091-6749(83)90526-2

データ提供:米国国立医学図書館(NLM)

Brompheniramine: A Cautionary Tale for Asthmatic Children

This study explores the potential adverse effects of brompheniramine, an antihistamine, on pulmonary function in a subset of asthmatic children. The research investigates the relationship between brompheniramine exposure and respiratory symptoms, particularly in children who experience chest tightness and wheezing after taking the medication. The authors perform a controlled challenge study to assess the impact of brompheniramine on pulmonary function, highlighting the potential risks associated with its use in certain asthmatic children. This study contributes to our understanding of the complex interplay between antihistamines and asthma, underscoring the importance of careful medication selection and individualized treatment approaches.

Brompheniramine: A Cautionary Note for Asthmatic Children

This study unveils the potential adverse effects of brompheniramine, an antihistamine, on pulmonary function in a subset of asthmatic children. The findings suggest that brompheniramine can trigger respiratory symptoms, particularly chest tightness and wheezing, in certain children. This research underscores the importance of considering individual patient characteristics and potential medication sensitivities when treating asthmatic children, ensuring the safe and effective management of their condition.

Brompheniramine: A Potential Pitfall in the Desert of Asthma Management

The desert of asthma management can be fraught with challenges, particularly in navigating the complex interplay between medications and individual patient responses. This study highlights a potential pitfall in the use of brompheniramine, an antihistamine, in certain asthmatic children. The findings emphasize the importance of careful medication selection and individualized treatment approaches, ensuring the safe and effective management of this chronic condition.

Dr.Camel's Conclusion

This study explores the potential adverse effects of brompheniramine, an antihistamine, on pulmonary function in a subset of asthmatic children. The findings suggest that brompheniramine can trigger respiratory symptoms, particularly chest tightness and wheezing, in certain children. This research underscores the importance of considering individual patient characteristics and potential medication sensitivities when treating asthmatic children, ensuring the safe and effective management of their condition.
Date :
  1. Date Completed 1983-10-08
  2. Date Revised 2019-07-23
Further Info :

Pubmed ID

6886255

DOI: Digital Object Identifier

10.1016/0091-6749(83)90526-2

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.